SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-24-005004
Filing Date
2024-01-19
Accepted
2024-01-19 19:41:51
Documents
1
Period of Report
2024-01-18

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT ownership.html 4  
1 OWNERSHIP DOCUMENT ownership.xml 4 3993
  Complete submission text file 0001213900-24-005004.txt   5441
Mailing Address 120 MOUNTAIN VIEW BOULEVARD BASKING RIDGE NJ 07920
Business Address
Zelenkofske Steven (Reporting) CIK: 0001578333 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41596 | Film No.: 24546838

Mailing Address 822 A1A NORTH SUITE 300 PONTE VEDRA FL 32082
Business Address 822 A1A NORTH SUITE 300 PONTE VEDRA FL 32082 904-300-0701
Cadrenal Therapeutics, Inc. (Issuer) CIK: 0001937993 (see all company filings)

IRS No.: 880860746 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)